Zenith Suspension
Formulation

The active substance of Azithromycin Monohydrate (Zenith®) 200 mg/5 mL powder for oral suspension is azithromycin monohydrate equivalent to 200 mg azithromycin per 5 mL.

Azithromycin Monohydrate

Zenith® Suspension

Prescription Drug

Formulation

The active substance of Azithromycin monohydrate (Zenith®) 200 mg / 5 mL powder for oral suspension is Azithromycin monohydrate equivalent to 200 mg azithromycin per 5 mL.

Indication

Azithromycin monohydrate (Zenith®) can be applied in situations where micro-organisms sensitive to azithromycin have caused:

  • upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, (see special warnings and special precautions for use*)
  • acute otitis media
  • lower respiratory tract infections: acute bronchitis and mild to moderately severe community acquired pneumonia
  • skin and soft tissue infections
  • uncomplicated Chlamydia trachomatis urethritis and cervicitis (see section on warnings and special precautions for use*)

* Considerations should be given to official guidance on the appropriate use of antibacterial agents.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.